ArticleBreast cancer research : BCR2018

HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women.

Anja Kathrin Wege et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.